Zdrowie i gospodarka · 18/02/2020

FDA to Host Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder

The FDA is seeking public input on its approach to treating stimulant use disorder, following a public meeting where stakeholders can share their perspectives on the issue.